Jiachen Wang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2026
Clinical Impact of BTK Inhibitor Exposure in LymphGen-Defined MCD Diffuse Large B-Cell Lymphoma.
Journal: Hematological oncology
Published: June 04, 2026
Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.
Journal: Blood cancer journal
Published: January 01, 2026
Elevated FGR protein expression identifies a high-risk subset of diffuse large B-cell lymphoma and a potential therapeutic target.
Journal: Frontiers in oncology
Published: August 19, 2025
ELF6 mutation suppresses the dwarf phenotype of Arabidopsis ino80 mutant by modulating cell cycle progression.
Journal: The New phytologist
Published: February 23, 2025
Structural and functional interrelationships of histone H2A with its variants H2A.Z and H2A.W in Arabidopsis.
Journal: Structure (London, England : 1993)
Published: February 21, 2025
Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial.
Journal: Blood cancer journal
Published: October 04, 2024
Histone chaperones AtChz1A and AtChz1B are required for H2A.Z deposition and interact with the SWR1 chromatin-remodeling complex in Arabidopsis thaliana.
Journal: The New phytologist
Published: February 15, 2023
Histone methylation readers MRG1/2 interact with PIF4 to promote thermomorphogenesis in Arabidopsis.
Histone methylation readers MRG1/2 interact with PIF4 to promote thermomorphogenesis in Arabidopsis.
Journal: Cell reports
Published: September 26, 2022
Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of extranodal natural killer (NK)/T-cell lymphoma.
Journal: Annals of translational medicine
Published: May 25, 2021
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients.
Journal: Cancer medicine
Published: February 06, 2020
Last Updated: 09/26/2026